Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

Clinical trial NCT00337779 · COMPLETED

Trial details

NCT number: NCT00337779
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2006-08-01
Primary completion: 2008-10-01
Enrollment: 1155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.